ArticleScientific reports2025
Dynamic kernel generation through hybrid involution and convolution neural networks for leukemia and white blood cell classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Blood cancer diagnosis through microscopic image analysis is challenging due to subtle morphological differences between cell stages and subtypes. This study aims to develop a Hybrid Involutional-Convolutional Neural Network (HICNN) for automated leukemia detection and white blood cell morphology analysis, enabling precise classification of leukemia stages and leukocyte subtypes to improve diagnostic accuracy. The HICNN integrates involution layers, which dynamically generate spatially adaptive kernels for context-specific feature extraction, with convolutional layers that capture translation-invariant hierarchical patterns. This hybrid architecture leverages parallel processing within hybrid blocks to enhance discrimination of subtle cellular variations. The HICNN achieved exceptional performance with 99.5% accuracy on a leukemia staging dataset and 98.00% accuracy on a leukocyte subtyping dataset, surpassing state-of-the-art models. Model reliability was demonstrated through Brier scores of 0.0019 and 0.0069, with inter-class misclassifications below 2% and minimal overlap between class confidence scores. Training performance showed stable convergence within 50 epochs, with validation accuracy exceeding 99% by epoch 30. The HICNN advances automated hematological diagnostics by successfully addressing feature discrimination and model calibration challenges. The framework demonstrates robust performance in both cancer staging and cell subtype classification tasks, showing promise for reducing diagnostic ambiguity and improving early detection in leukemia and related hematological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.